磁共振T1和T2定量成像评估肾脏结构与功能:系统综述与声明文件
本文由欧洲PARENCHIMA行动发起,系统综述了肾脏磁共振弛豫测量(MRR)在非肿瘤性肾病中的临床应用。健康人T1可见皮髓质分化(CMD),T2仅有轻微CMD;急性排异反应(AAR)表现为皮质T1升高(T1 CMD减低),慢性排异反应T1 CMD减低,但AAR与急性肾小管坏死及环孢素肾毒性难以充分区分。T1 CMD与肾功能呈中至强相关,T2在移植肾和早期ADPKD中升高。因缺乏标准化,目前无广泛接受的参考值,呼吁优化和标准化多参数协议。
要点
- 健康人T1可见皮髓质分化,T2仅有轻微皮髓质分化。
- 移植肾急性排异反应表现为皮质T1升高(T1 CMD减低)。
- T1 CMD与肾功能呈中至强相关,但特异性受灌注等因素影响。
核心结论
- 肾脏磁共振弛豫测量对多种病理过程敏感,但缺乏标准化和参考值,需优化协议以提高特异性。
研究设计与样本
- 系统综述,由欧洲COST行动PARENCHIMA发起,聚焦1.5T和3T下T1和T2定量测量在肾脏非肿瘤疾病中的应用。
主要发现
- 健康人T1可见皮髓质分化,T2仅有轻微皮髓质分化。
- 急性排异反应表现为皮质T1升高(T1 CMD减低),慢性排异反应T1 CMD减低,但急性排异反应与急性肾小管坏死及环孢素肾毒性难以充分区分。
- 一项近期定量研究显示移植肾纤维化与T1 CMD直接相关。
- 多种肾脏疾病(包括移植肾)中T1 CMD与肾功能呈中至强相关。
- 近期T2研究观察到移植肾和早期ADPKD中T2值升高,早期ADPKD中可能优于单纯总肾体积评估。
关键数值与推荐
- 健康人T1可见皮髓质分化,T2仅有轻微皮髓质分化。
- 急性排异反应表现为皮质T1升高(T1 CMD减低),慢性排异反应T1 CMD减低。
- 移植肾纤维化与T1 CMD直接相关。
- 多种肾脏疾病中T1 CMD与肾功能呈中至强相关。
- 早期ADPKD中T2值升高。
临床怎么用
- 目前肾脏MRR尚无广泛接受的参考值,临床常规应用需谨慎。
- 建议参与优化和标准化多参数协议,以提高特异性并挖掘MRR潜力。
局限性
- 患者准备、采集协议和患者选择缺乏标准化。
- MRR对灌注、缺血/氧合、水肿、纤维化、水合状态和合并症敏感,降低特异性。
- 急性排异反应与急性肾小管坏死及环孢素肾毒性难以充分区分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This systematic review, initiated by the European Cooperation in Science and Technology Action Magnetic Resonance Imaging Biomarkers for Chronic Kidney Disease (PARENCHIMA), focuses on potential clinical applications of magnetic resonance imaging in renal non-tumour disease using magnetic resonance relaxometry (MRR), specifically, the measurement of the independent quantitative magnetic resonance relaxation times T1 and T2 at 1.5 and 3Tesla (T), respectively. Healthy subjects show a distinguishable cortico-medullary differentiation (CMD) in T1 and a slight CMD in T2. Increased cortical T1 values, that is, reduced T1 CMD, were reported in acute allograft rejection (AAR) and diminished T1 CMD in chronic allograft rejection. However, ambiguous findings were reported and AAR could not be sufficiently differentiated from acute tubular necrosis and cyclosporine nephrotoxicity. Despite this, one recent quantitative study showed in renal transplants a direct correlation between fibrosis and T1 CMD. Additionally, various renal diseases, including renal transplants, showed a moderate to strong correlation between T1 CMD and renal function. Recent T2 studies observed increased values in renal transplants compared with healthy subjects and in early-stage autosomal dominant polycystic kidney disease (ADPKD), which could improve diagnosis and progression assessment compared with total kidney volume alone in early-stage ADPKD. Renal MRR is suggested to be sensitive to renal perfusion, ischaemia/oxygenation, oedema, fibrosis, hydration and comorbidities, which reduce specificity. Due to the lack of standardization in patient preparation, acquisition protocols and adequate patient selection, no widely accepted reference values are currently available. Therefore this review encourages efforts to optimize and standardize (multi-parametric) protocols to increase specificity and to tap the full potential of renal MRR in future research.
引用
- Wolf M, de Boer A, Sharma K, et al. Magnetic resonance imaging T1- and T2-mapping to assess renal structure and function: a systematic review and statement paper. Nephrol Dial Transplant. 2018. PMID: 30137583. doi:10.1093/ndt/gfy198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。